Endometrial cancer screening in Lynch syndrome: Do patients report symptoms prior to diagnosis?

2013 ◽  
Vol 130 (1) ◽  
pp. e100-e101
Author(s):  
K. Ring ◽  
S. Boyd-Rogers ◽  
Y. Amin ◽  
M. Daniels ◽  
B. Batte ◽  
...  
2011 ◽  
Vol 7 (1) ◽  
pp. 43-47 ◽  
Author(s):  
Marilyn Huang ◽  
Charlotte Sun ◽  
Stephanie Boyd-Rogers ◽  
Jennifer Burzawa ◽  
Andrea Milbourne ◽  
...  

Combined colon and endometrial cancer screening is a patient-centered approach that is feasible and acceptable and may improve adherence to Lynch syndrome screening recommendations.


2011 ◽  
Vol 29 (15_suppl) ◽  
pp. 5108-5108
Author(s):  
A. Bats ◽  
M. Le Frere-Belda ◽  
U. Metzger ◽  
P. Laurent-Puig ◽  
F. Lecuru

2008 ◽  
Vol 26 (6) ◽  
pp. 948-954 ◽  
Author(s):  
Donald W. Hadley ◽  
Jean F. Jenkins ◽  
Seth M. Steinberg ◽  
David Liewehr ◽  
Stephanie Moller ◽  
...  

Purpose Lynch syndrome poses multiple cancer risks, yet attention has focused on screening for colorectal cancer. Estimated risks for endometrial cancer equal risks for colorectal cancer. This study (1) evaluated women's perceived risks for cancers, (2) compared endometrial cancer screening and colonoscopy, and (3) identified predictors of screening before and after genetic testing. Patients and Methods Sixty-five adult women at 50% risk for carrying a cancer-predisposing mutation, without a history of endometrial cancer or hysterectomy, participated in genetic counseling and received unequivocal genetic test results for Lynch syndrome. Participants completed questionnaires before and after receipt of genetic results. Results Pretest, perceived risks for colon cancer were significantly higher than for extracolonic cancers (P < .0001). Use of colonoscopy was significantly higher (P = .006) than endometrial cancer screening. Post-test, carriers demonstrated a significant (P < .0001) increase in their perceived risk for extracolonic cancers and increased both colonoscopy (P = .79) and endometrial cancer screening (P = .11). Mutation status, age, perceived likelihood of carrying a mutation, and communication of test results to their physician independently predicted cancer screening at follow-up. Conclusion Women in families with Lynch syndrome are less aware of their risks for extracolonic cancers and undergo endometrial cancer screening significantly less often than colonoscopy before genetic counseling. Given the significantly increased risks for endometrial and ovarian cancers and the mortality associated with ovarian cancer, additional efforts to inform families of cancer risks and screening recommendations seem prudent. Physicians play a critical role in ensuring appropriate cancer screening in women with Lynch syndrome.


2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 1563-1563
Author(s):  
M. Huang ◽  
C. C. Sun ◽  
S. Boyd-Rogers ◽  
J. K. Burzawa ◽  
A. Milbourne ◽  
...  

2019 ◽  
Vol 30 (1) ◽  
pp. 56-61
Author(s):  
Giorgio Bogani ◽  
Maria Grazia Tibiletti ◽  
Maria Teresa Ricci ◽  
Ileana Carnevali ◽  
Viola Liberale ◽  
...  

ObjectiveWomen with Lynch syndrome have a risk up to 40–60% of developing endometrial cancer, which is higher than their risk of developing colorectal or ovarian cancer. To date, no data on the outcomes of patients with Lynch syndrome diagnosed with non-endometrioid endometrial cancer are available. The goal of this study was to evaluate the outcome of patients with Lynch syndrome diagnosed with non-endometrioid endometrial cancer.MethodsData from consecutive patients diagnosed with Lynch syndrome and with a histological diagnosis of non-endometrioid endometrial cancer were retrospectively collected in two referral institutes in Italy. A case–control comparison (applying a propensity matching algorithm) was performed in order to compare patients with proven Lynch syndrome and controls. Inclusion criteria were: (a) histologically-proven endometrial cancer; (b) detection of a germline pathogenic variant in one of the MMR genes; (c) adequate follow-up. Only carriers of pathogenic or likely pathogenic variants (ie, class 5 and 4 according to the InSiGHT classification) were included in the study. Survival outcomes were assessed using KaplanMeier and Cox models.ResultsOverall, 137 patients with Lynch syndrome were collected. Mean patient age was 49.2 (10.9) years. Genes involved in the Lynch syndrome included MLH1, MSH2, and MSH6 in 43%, 39%, and 18% of cases, respectively. The study population included 27 patients with non-endometrioid endometrial cancer, who were matched 1:2 with patients with sporadic cancers using a propensity matching algorithm. After a median follow-up of 134 months (range 1–295), 2 (7.4%) of the 27 patients developed recurrent disease (3 and 36 months) and subsequently died of disease (7 and 91 months). Patients diagnosed with Lynch syndrome experienced better disease-free survival (HR 7.86 (95% CI 1.79 to 34.5); p=0.006) and overall survival (HR 5.33 (95% CI 1.18 to 23.9); p=0.029) than controls.ConclusionsNon-endometrioid endometrial cancer occurring in patients with Lynch syndrome might be associated with improved oncologic outcomes compared with controls. Genetic/molecular profiling should be investigated in order to better understand the mechanism underlying the prognosis.


2009 ◽  
Vol 136 (5) ◽  
pp. A-624
Author(s):  
Marvin Singh ◽  
Emily Singh ◽  
Heather Miller ◽  
Williamson Strum ◽  
Walter Coyle

2022 ◽  
Vol 164 (1) ◽  
pp. 4-5
Author(s):  
Isabel Rodriguez ◽  
Sarah Strickland ◽  
David Wells ◽  
Enna Manhardt ◽  
Eric Konnick ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document